Trial Profile
A Randomised, Parallel Group, Assessor-Blind, Multicentre Study to Compare the Safety and Efficacy of Actavis rhFSH with Follitropin Alfa (GONAL-f) in Stimulating Multiple Follicular Development in Women Participating in an Assisted Reproductive Technology Program
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 30 Mar 2017
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Sponsors Watson Laboratories
- 29 Mar 2017 Status changed from recruiting to discontinued.
- 13 Aug 2014 New trial record